4//SEC Filing
WEHRWEIN SVEN 4
Accession 0001205069-25-000007
CIK 0001323885other
Filed
Nov 25, 7:00 PM ET
Accepted
Nov 26, 4:43 PM ET
Size
13.3 KB
Accession
0001205069-25-000007
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
WEHRWEIN SVEN
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-24$19.95/sh+5,033$100,408→ 39,407 total - Sale
Common Stock
2025-11-24$37.32/sh−5,033$187,832→ 34,374 total - Exercise/Conversion
Common Stock
2025-11-25$19.95/sh+4,967$99,092→ 39,341 total - Sale
Common Stock
2025-11-25$38.00/sh−4,967$188,746→ 34,374 total - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2025-11-24−5,033→ 29,967 totalExercise: $19.95From: 2017-11-11Exp: 2026-11-11→ Non-qualified Stock Option (right to buy) (5,033 underlying) - Exercise/Conversion
Non-qualified Stock Option (right to buy)
2025-11-25−4,967→ 25,000 totalExercise: $19.95From: 2017-11-11Exp: 2026-11-11→ Non-qualified Stock Option (right to buy) (4,967 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $37.32 to $38.00 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001205069
Filing Metadata
- Form type
- 4
- Filed
- Nov 25, 7:00 PM ET
- Accepted
- Nov 26, 4:43 PM ET
- Size
- 13.3 KB